SRDX - SurModics - Biotech IPO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRDX - SurModics - Biotech IPO

SRDX 26.95

-1.6%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Lance Bredvold	6/8/2023 4:16:13 PM
	of 84

Today SRDX rose 8% without any apparent justification except that investors seem to feel Surveil may be approved any moment. And I am pleased with my analysis suggesting the delay is just a typical FDA speed bump which every biotech I'm involved in has suffered many times. Thus the shock which brought SRDX down to $16 was not justified by that one event and offered an opportunity to me to buy more. Wish I'd bought more than I did and started way up at $25 which has not been achieved yet, but I feel the volatility being displayed indicates investors really don't know which way to jump yet. I own a significant portion of my portfolio in SRDX and have for many years (2003). And despite the EPS going sideways most of the time, I feel I've had a good return on my investment by buying low and selling high. Plus lots of call sales due to wonderful volatility.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next